跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Citrapos XR - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Citrapos XR
Approved
STANDARD
Citrapos XR
Cooper Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8220bf3215d8471b
Company
Cooper Pharma Limited
Type
Standard
Approval Details
Approval Id
8220bf3215d8471b
Drug Approval Philippines Name
Citrapos XR
Product Name
Citrapos XR
Registration Number
DRP-14484-01
Brand Name
Citrapos XR
Generic Name
Potassium citrate
Dosage Form
Extended-Release Tablet
Dosage Strength
1.620 g (15 mEq)
Manufacturer
Cooper Pharma Limited
Importer
Ambica International Corporation
Distributor
Corbridge Group Phils., Inc.
Issuance Date
27 December 2023
Expiry Date
12 September 2028
Pharmacologic Category
Antiurolithic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8220bf3215d8471b
Type
Standard
Back to Philippines FDA Approvals